GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (NAS:CLOV) » Definitions » Beneish M-Score

Clover Health Investments (Clover Health Investments) Beneish M-Score : -3.84 (As of May. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.84 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Clover Health Investments's Beneish M-Score or its related term are showing as below:

CLOV' s Beneish M-Score Range Over the Past 10 Years
Min: -6.9   Med: -5.33   Max: -3.84
Current: -3.84

During the past 5 years, the highest Beneish M-Score of Clover Health Investments was -3.84. The lowest was -6.90. And the median was -5.33.


Clover Health Investments Beneish M-Score Historical Data

The historical data trend for Clover Health Investments's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments Beneish M-Score Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - -5.33 -6.90 -3.84

Clover Health Investments Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.90 -3.95 -4.21 -3.14 -3.84

Competitive Comparison of Clover Health Investments's Beneish M-Score

For the Healthcare Plans subindustry, Clover Health Investments's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clover Health Investments's Beneish M-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Beneish M-Score falls into.



Clover Health Investments Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Clover Health Investments for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1615+0.528 * 0.0517+0.404 * 1.0941+0.892 * 0.585+0.115 * 0.4734
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.5686+4.679 * -0.120225-0.327 * 0.8593
=-3.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $114 Mil.
Revenue was 510.251 + 482.066 + 513.628 + 527.775 = $2,034 Mil.
Gross Profit was 62.266 + 63.107 + 76.674 + 55.285 = $257 Mil.
Total Current Assets was $428 Mil.
Total Assets was $571 Mil.
Property, Plant and Equipment(Net PPE) was $8 Mil.
Depreciation, Depletion and Amortization(DDA) was $3 Mil.
Selling, General, & Admin. Expense(SGA) was $447 Mil.
Total Current Liabilities was $261 Mil.
Long-Term Debt & Capital Lease Obligation was $3 Mil.
Net Income was -70.472 + -41.469 + -28.814 + -72.606 = $-213 Mil.
Non Operating Income was -22.818 + -1.313 + -4.75 + 0 = $-29 Mil.
Cash Flow from Operations was -229.295 + -18.781 + 53.173 + 79.032 = $-116 Mil.
Total Receivables was $168 Mil.
Revenue was 898.791 + 856.817 + 846.7 + 874.379 = $3,477 Mil.
Gross Profit was 5.146 + 17.018 + -12.086 + 12.657 = $23 Mil.
Total Current Assets was $625 Mil.
Total Assets was $809 Mil.
Property, Plant and Equipment(Net PPE) was $10 Mil.
Depreciation, Depletion and Amortization(DDA) was $1 Mil.
Selling, General, & Admin. Expense(SGA) was $487 Mil.
Total Current Liabilities was $432 Mil.
Long-Term Debt & Capital Lease Obligation was $4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(113.832 / 2033.72) / (167.545 / 3476.687)
=0.055972 / 0.048191
=1.1615

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(22.735 / 3476.687) / (257.332 / 2033.72)
=0.006539 / 0.126533
=0.0517

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (427.97 + 8.464) / 570.671) / (1 - (624.997 + 9.778) / 808.62)
=0.235227 / 0.21499
=1.0941

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2033.72 / 3476.687
=0.585

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.187 / (1.187 + 9.778)) / (2.509 / (2.509 + 8.464))
=0.108254 / 0.228652
=0.4734

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(446.535 / 2033.72) / (486.642 / 3476.687)
=0.219566 / 0.139973
=1.5686

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.998 + 261.115) / 570.671) / ((4.033 + 431.507) / 808.62)
=0.462811 / 0.538621
=0.8593

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-213.361 - -28.881 - -115.871) / 570.671
=-0.120225

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Clover Health Investments has a M-score of -3.84 suggests that the company is unlikely to be a manipulator.


Clover Health Investments Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Clover Health Investments (Clover Health Investments) Business Description

Traded in Other Exchanges
Address
3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.
Executives
Karen Soares officer: General Counsel & Secretary 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Clover Health Investments, Corp. /de officer: Chief Technology Officer 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Anna U Loengard director C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Andrew Toy director, officer: Chief Executive Officer C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Scott J. Leffler officer: Chief Financial Officer C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Brady Patrick Priest officer: CEO of Home Care C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067
Demetrios L. Kouzoukas director C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067
Aric R Sharp officer: CEO of Value-Based Care C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Wai Conrad officer: Chief Technology Officer 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Joseph Richards Martin officer: General Counsel C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219
Vivek Garipalli director, 10 percent owner, officer: Executive Chairperson C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Carladenise Armbrister Edwards director C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Chelsea Clinton director C/O IAC 555 W 18TH STREET, NEW YORK NY 10011
Jamie L. Reynoso officer: CEO of Medicare Advantage C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Chamath Palihapitiya 10 percent owner, other: See Remarks THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025